Effectiveness of therapeutic ultrasound versus transcutaneous electric nerve stimulation as a pain controlling modality in temporomandibular joint disorders : a randomized control trial

Dr LAKSHMI B0 个研究点目标入组 40 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•1. TMD patients with clinical features of pain and masticatory muscle tenderness, pain while opening and closing mouth in the age group of 18-50 years.
•2. Patients being treated with other drug therapy will be considered provided a washout period of at least 3 weeks will be allowed before inclusion in the study

•1. Patients with definite radiographic changes involving TMJ.
•2. Patients with a history of maxillofacial trauma.
•3. Patients with a history of polyarthritis, joint infection, surgical treatment, physiotherapy, splint therapy, or acupuncture within the 4 months before the study
•4. Orofacial infections and developmental anomalies of the maxillofacial region.
•5. Patients with cardiac pacemakers, history of seizures, depression, other mental and vascular disorders, bleeding disorders, respiratory disease, and other diseases that might impact the outcome assessments.
•6. Pregnancy
•7. Patients with brain tumors, neoplasia, or neurological disorders involving the head and neck like Bell’s palsy, multiple sclerosis, and Tourette syndrome.
•8. Patients who have been treated with TENS or Ultrasound therapy previously without any improvement in the conditions.
•9. Allergy to adhesive tapes or electrodes of TENS or Ultrasound gel.

发起方

Dr LAKSHMI B